Funder
U.S. Department of Defense
Mayo Clinic
Subject
Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism
Reference9 articles.
1. The use of targeted mouse models for preclinical testing of novel cancer therapeutics;Olive;Clin Cancer Res,2006
2. Genetically engineered mouse models of pancreatic cancer: the KPC model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), its variants, and their application in immuno-oncology drug discovery;Lee;Curr Protoc Pharmacol,2016
3. Pancreas-specific Cre driver lines and considerations for their prudent use;Magnuson;Cell Metabol,2013
4. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice;Hingorani;Cancer Cell,2005
5. Genetic progression of pancreatic cancer;Cowan;Cancer J,2014